Fratagene Therapeutics

Cutting edge science in a passionate environment. Our commitment at Fratagene is to find effective therapeutics for Friedreich ataxia. About Friedreich ataxia. Over 15,000 patients, mostly children, are affected by Friedreich ataxia in US, Canada and EU only. The disease causes progressive disability and reduced life expectancy. There is no approved cure for Friedreich ataxia. Friedreich ataxia received Orphan Disease Designations by both the FDA and the EMA.

Biotechnology
Rome, Rome
Founded in unknown
1-10 employees

Cutting edge science in a passionate environment. Our commitment at Fratagene is to find effective therapeutics for Friedreich ataxia. About Friedreich ataxia. Over 15,000 patients, mostly children, are affected by Friedreich ataxia in US, Canada and EU only. The disease causes progressive disability and reduced life expectancy. There is no approved cure for Friedreich ataxia. Friedreich ataxia received Orphan Disease Designations by both the FDA and the EMA.

Company Information

Industry
Biotechnology
Company Type
Privately Held
Founded
unknown
Employee Range
1-10
Revenue Range
Not available

Location

Address
City
Rome
Region
Rome
Postal Code
Country
Italy

Web Presence

Ready to automate your outreach?

Get unlimited access to our company database — complete with detailed profiles, funding info, and tech stacks — and start sending personalized emails with AI-powered follow-ups.

Frequently Asked Questions